US2015197751A1PendingUtilityA1

Rnai expression constructs

57
Assignee: BENITEC INCPriority: Feb 3, 2005Filed: Mar 30, 2015Published: Jul 16, 2015
Est. expiryFeb 3, 2025(expired)· nominal 20-yr term from priority
C12N 2310/531C12N 15/111C12N 2770/24211C12N 2310/14C12N 2310/111C12N 2310/53C12N 2310/51C12N 2330/30C12N 15/1131C12N 15/113
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A genetic construct capable of modifying expression of one or more genes, the genetic construct comprising an RNAi expression cassette comprising a promoter and two or more stem-loop structures separated by one or more spacer regions, the stem-loop structures being RNAi agents when transcribed from the promoter. 
     
     
         2 . The genetic construct of  claim 1  wherein the stem-loop structures target one or more sequences as set forth in any of SEQ ID No: 1-56. 
     
     
         3 . A 1-x RNA expression cassette comprising a promoter and two or more stem-loop structures separated from one another by one or more spacer regions, the cassette encoding two or more RNAi agents for modifying target gene expression. 
     
     
         4 . The cassette of  claim 3  wherein the stem-loop structures target one or more sequences as set forth in any of SEQ ID No: 1-56. 
     
     
         5 . A method of modifying the expression of one or more genes, comprising:
 introducing to a cell, tissue, or organ of interest a genetic construct comprising an RNAi expression cassette comprising a promoter and two or more stem-loop structures separated from one another by one or more spacer regions, the stem-loop structures being RNAi agents when transcribed from the promoter.   
     
     
         6 . The method of claim  13  wherein the stem-loop structures target one or more sequences as set forth in any of SEQ ID NO: 1-56.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.